Consumer telehealth · Virtual primary care and weight management
LifeMD
LifeMD is a virtual care company offering primary care, weight management with GLP-1 medications, and women's and men's health through a monthly membership, with insurance accepted for visits and many medications.
Strong fit
- Insured patients who want help getting Wegovy or Zepbound covered
- Patients who want one account for primary care and specialty programs
- People who want a video visit within the hour
Weak fit
- Patients who want simple, low recurring bills
- Anyone who needs fast human support on refills
- Patients looking for low-cost compounded GLP-1s
Bottom line
LifeMD is a publicly traded virtual care company that sells primary care, weight management, and men's and women's health through a monthly membership, with insurance accepted. It suits insured patients who want help getting branded GLP-1 medications covered. Patients who want simple, low recurring bills should read every fee before signing up.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
LifeMD is used by adults who want a virtual primary care clinician and specialty programs in one account, most often for weight loss with GLP-1 medications. Patients pay a monthly membership, book video visits that LifeMD says are available within an hour, and get prescriptions sent to a pharmacy. The care team checks whether a patient's insurance covers GLP-1 medication and what the copay would be.
LifeMD is priced in the middle of the market. The weight management program costs $39 for the first month and $149 a month after that, with medication billed separately through insurance or self-pay, and it lists self-pay Wegovy pens from $199 and Zepbound vials from $299. Henry Meds bundles compounded medication and visits from $179 a month, and Sesame sells one-off cash visits.
The closest competitors are Sesame, Found, Henry Meds, and Mochi Health.
Justin Schreiber co-founded LifeMD with Stefan Galluppi and has been chief executive and chairman since 2018, according to its investor site. The company reported revenue of $194.1 million for 2025, up from $154.8 million in 2024, and about 323,000 subscribers in its results release, which guided to $220 million to $230 million for 2026.
The complaints on Trustpilot focus on billing and refills. Patients describe monthly fees they did not expect, charges after canceling, and refill requests that needed repeated calls. LifeMD's weight program page says medication cost is not included in the $149 monthly fee.
What patients say
Patients on Trustpilot rate LifeMD 3.9 from 4,281 reviews. Here is what they like and dislike.
"Kelly P. listened to me and did not rush the appointment. We discussed symptoms and medication options as a team; which is very important to me in a healthcare setting." Trustpilot
"The signup and first zepbound shipment went smoothly." Trustpilot
"They bring you in with great prices. Rates go up fast then they prebill you for services." Trustpilot
"I had repeated call customer service each month to get a refill." Trustpilot
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Found | 7.4 | 7.2 |
| Mochi Health | 7.0 | 6.6 |
| LifeMD | 6.9 | 7.0 |
| Sesame | 6.8 | 6.7 |
| Henry Meds | 6.7 | 6.3 |
Pricing
| Item | Detail |
|---|---|
| Model | LifeMD charges a monthly membership and program fees, with visits billed to insurance or paid in cash and medication paid separately. |
| What usually drives cost | For LifeMD, cost depends on the program you join, whether your insurance covers visits and medication, and which GLP-1 you take. |
| What to ask before you buy | Ask LifeMD for every recurring charge on your account, what your insurance will cover, and how to cancel each one. |
| Note | LifeMD says copays can be as low as $25 for Zepbound, Wegovy, and other branded GLP-1s for eligible insured patients. |
| Published pricing | The weight management program costs $39 for the first month, then $149 a month, with medication extra. Self-pay Wegovy pens start at $199 and Zepbound vials at $299. |
Leadership
Justin SchreiberCo-founder, CEO, and Chairman- Stefan GalluppiCo-founder and Chief Innovation Officer
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.